Long Shortz with AdAlta: Growing in confidence every day for fibrotic medical treatments
Stockhead TV
share
Stockhead’s Sarah Hughan sits down withAdAlta’s (ASX:1AD) CEO and MD Tim Oldham to get the short end of the long story on the company’s latest news.
The biotech has appointed consultant chief medical officers for its AdCella and AdSolis subsidiaries.
It also released its September quarterly activities report, highlighting the progress of its AD-214 formulation.
Tune in to hear AdAlta’s Tom Oldham on the prestigious advisors, the company’s busy business activity, and more.
This video was developed in collaboration with AdAlta, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
Read MoreHealth
